CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site

Journal of Experimental Medicine

Volumn 190, Issue 9, 1999, Pages 1215-1225

  Sonoda, Koh Hei ^a   Exley, Mark ^b   Snapper, Scott ^c   Balk, Steven P ^b   Stein Streilein, Joan ^a,d  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anterior chamber associated immune deviation; Autoimmunity; i.v. tolerance; Immune deviation; Innate immunity

Indexed keywords

CD1 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR EYE CHAMBER DISEASE; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD1; AUTOIMMUNITY; CELLS, CULTURED; EYE; FEMALE; FLOW CYTOMETRY; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; SPLEEN; T-LYMPHOCYTES;

EID: 0033230839     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.9.1215     Document Type: Article

References (55)

1. Streilein, J.W. 1993. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 5:428-432.
2. Griffith, T.S., T. Brunner, S.M. Fletcher, D.R. Green, and T.A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1189-1192.
3. Taylor, A.W., J.W. Streilein, and S.W. Cousins. 1992. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye. Res. 11:1199-1206.
4. Taylor, A.W., J.W. Streilein, and S.W. Cousins. 1994. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 153:1080-1086.
5. Streilein, J.W., and D. Bradley. 1991. Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products. Invest. Ophthalmol. Vis. Sci. 32:2700-2710.
6. Cousins, S.W., M.M. McCabe, D. Danielpour, and J.W. Streilein. 1991. Identification of transforming growth factor -beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 32:2201-2211.
7. Streilein, J.W., G.A. Wilbanks, and S.W. Cousins. 1992. Immunoregulatory mechanisms of the eye. J. Neuroimmunol. 39: 185-200.
8. Streilein, J.W., B.R. Ksander, and A.W. Taylor. 1997. Immune deviation in relation to ocular immune privilege. J. Immunol. 158:3557-3560.
9. Streilein, J.W. 1987. Immune regulation and the eye: a dangerous compromise. FASEB J. 1:199-208.
10. Streilein, J.W., and J.Y. Niederkorn. 1981. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J. Exp. Med. 153:1058-1067.
11. Wilbanks, G.A., and J.W. Streilein. 1990. Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes. Immunology. 71:566-572.
12. Wilbanks, G.A., and J.W. Streilein. 1992. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg. Immunol. 4:130-137.
13. Streilein, J.W., and J.Y. Niederkorn. 1985. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. J. Immunol. 134:1381-1387.
14. Wilbanks, G.A., and J.W. Streilein. 1990. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology. 71:383-389.
15. Li, X.Y., L.T. D'Orazio, and J.Y. Niederkorn. 1996. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology. 89:34-40.
16. Kosiewicz, M.M., P. Alard, and J.W. Streilein. 1998. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production. J. Immunol. 161:5382-5390.
17. Hara, Y., S. Okamoto, B. Rouse, and J.W. Streilein. 1993. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type. J. Immunol. 151:5162-5171.
18. Griffith, T.S., X. Yu, J.M. Herndon, D.R. Green, and T.A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 5:7-16.
19. Yoshimoto, T., A. Bendelac, C. Watson, J. Hu-Li, and W.E. Paul. 1995. Role of NK1.1 + T cells in a TH2 response and in immunoglobulin E production. Science. 270:1845-1847.
20. Mieza, M.A., T. Itoh, J.Q. Cui, Y. Makino, T. Kawano, K. Tsuchida, T. Koike, T. Shirai, H. Yagita, A. Matsuzawa, H. Koseki, and M. Taniguchi. 1996. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156:4035-4040.
21. Yoshimoto, T., A. Bendelac, J. Hu-Li, and W.E. Paul. 1995. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1 + T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA. 92:11931-11934.
22. Bendelac, A., M.N. Rivera, S.H. Park, and J.H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562.
23. - T cells in mice and humans. J. Exp. Med. 180:1097-1106.
24. Makino, Y., R. Kanno, T. Ito, K. Higashino, and M. Taniguchi. 1995. Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations. Int. Immunol. 7:1157-1161.
25. Shimamura, M., T. Ohteki, U. Beutner, and H.R. MacDonald. 1997. Lack of directed V alpha 14-J alpha 281 rearrangements in NK1+ T cells. Eur. J. Immunol. 27:1576-1579.
26. - α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain. J. Exp. Med. 178:1-16.
27. - T cells. J. Exp. Med. 180:1171-1176.
28. - subset. J. Exp. Med. 177:1763-1771.
29. - T cells. J. Exp. Med. 186:109-120.
30. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182: 2091-2096.
31. Bendelac, A., O. Lantz, M.E. Quimby, J.W. Yewdell, J.R. Bennink, and R.R. Brutkiewicz. 1995. CD1 recognition by mouse NK1+ T lymphocytes. Science. 268:863-865.
32. Chen, Y.H., N.M. Chiu, M. Mandal, N. Wang, and C.R. Wang. 1997. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity. 6:459-467.
33. Mendiratta, S.K., W.D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 6:469-477.
34. Smiley, S.T., M.H. Kaplan, and M.J. Grusby. 1997. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science. 275:977-979.
35. Chen, H., H. Huang, and W.E. Paul. 1997. NK1.1+ CD4+ T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 158:5112-5119.
36. Asea, A., and J. Stein-Streilein. 1998. Signalling through NK1.1 triggers NK cells to die but induces NK T cells to produce interleukin-4. Immunology. 93:296-305.
37. Hara, Y., R.R. Caspi, B. Wiggert, C.C. Chan, G.A. Wilbanks, and J.W. Streilein. 1992. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein. J. Immunol. 148:1685-1692.
38. Sumida, T., A. Sakamoto, H. Murata, Y. Makino, H. Takahashi, S. Yoshida, K. Nishioka, I. Iwamoto, and M. Taniguchi. 1995. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182:1163-1168.
39. Wilson, S.B., S.C. Kent, K.T. Patton, T. Orban, R.A. Jackson, M. Exley, S. Porcelli, D.A. Schatz, M.A. Atkinson, S.P. Balk, J.L. Strominger, and D.A. Hafler. 1998. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature. 391:177-181.
40. Gombert, J.M., A. Herbelin, E. Tancrede-Bohin, M. Dy, C. Carnaud, and J.F. Bach. 1996. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 26:2989-2998.
41. Baxter, A.G., S.J. Kinder, K.J. Hammond, R. Scollay, and D.I. Godfrey. 1997. Association between alphabetaTCR+ CD4-CD8-T-cell deficiency and IDDM in NOD/Lt mice. Diabetes. 46:572-582.
42. Hara, Y., R.R. Caspi, B. Wiggert, M. Dorf, and J.W. Streilein. 1992. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye [published erratum appears in J. Immunol. 149:4116]. J. Immunol. 149:1531-1538.
43. Wilbanks, G.A., M. Mammolenti, and J.W. Streilein. 1992. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Enr. J. Immunol. 22:165-173.
44. D'Orazio, T.J., and J.Y. Niederkorn. 1998. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology. 95:47-55.
45. Niederkorn, J.Y., and E. Mayhew. 1995. Role of splenic B cells in the immune privilege of the anterior chamber of the eye. Eur. J. Immunol. 25:2783-2787.
46. Roark, J.H., S.H. Park, J. Jayawardena, U. Kavita, M. Shannon, and A. Bendelac. 1998. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160:3121-3127.
47. D'Orazio, T.J., and J.Y. Niederkorn. 1998. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J. Immunol. 160:2089-2098.
48. Gao, Y., J.M. Herndon, H. Zhang, T.S. Griffith, and T.A. Ferguson. 1998. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188:887-896.
49. Tamada, K., M. Harada, K. Abe, T. Li, H. Tada, Y. Onoe. and K. Nomoto. 1997. Immunosuppressive activity of cloned natural killer (NK1.1+) T cells established from murine tumor-infiltrating lymphocytes. J. Immunol. 158:4846-4854.
50. Takeuchi, M., M.M. Kosiewicz, P. Alard, and J.W. Streilein. 1997. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T-cell activation. Eur. J. Immunol. 27:1648-1656.
51. Seki, S., W. Hashimoto, K. Ogasawara, M. Satoh, H. Watanabe, Y. Habu, H. Hiraide, and K. Takeda. 1997. Antimetastatic effect of NK1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice. Immunology. 92:561-566.
52. Zhang, B., T. Yamamura, T. Kondo, M. Fujiwara, and T. Tabira. 1997. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186: 1677-1687.
53. Kosiewicz, M.M., S. Okamoto, S. Miki, B.R. Ksander, T. Shimizu, and J.W. Streilein. 1994. Imposing deviant immunity on the presensitized state. J. Immunol. 153:2962-2973.
54. Mueller, D.L., M.K. Jenkins, and R.H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a co-stimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445-480.
55. Zeng, D., D. Lewis, S. Dejbakhsh-Jones, F. Lan, M. Garcia-Ojeda, R. Sibley, and S. Strober. 1999. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J. Exp. Med. 189:1073-1081.